FDA Approves Baxdrostat for Resistant Hypertension - Top-Institutions - MDSpire

FDA Approves Baxdrostat for Resistant Hypertension

  • By

  • Kathryn Wighton

  • May 18, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University College London
    University College London

    London, England

    Key Differentiators

    • Cardiology

  • #2

    Sierra Eye Associates
    Sierra Eye Associates

    Sierra Vista, Arizona

    Key Differentiators

    • Ophthalmology

  • #3

    Columbia University College of Physicians and Surgeons
    Columbia University College of Physicians and Surgeons

    New York, New York

    Key Differentiators

    • Medicine

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Medicine

Original Source(s)

FDA Approves Baxdrostat for Resistant Hypertension

  • by Kathryn Wighton

  • May 18, 2026

Related Content

Non-Invasive Testing for Coronary Artery Disease

Dr. Uprety discusses the current role of non-invasive testing for coronary artery disease, highlighting evidence-based diagnostic strategies and the appropriate use of imaging modalities to improve early detection, risk stratification, and clinical decision-making.

  • May 18, 2026

Non-Invasive Techniques In Pediatric Dyslipidemia

Damon B. Dixon, MD, at Phoenix Children’s Cardiology, is the author to this EndoText chapter. Dr. Dixon brings nationally recognized expertise in pediatric cardiovascular risk assessment and non?invasive vascular imaging.

  • by

  • May 15, 2026

  • 1 min
LV Function Mostly Preserved After ASO

CMR findings were largely reassuring in most patients, although late gadolinium enhancement was identified in a minority